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Memory CD8+ T cell quantity and quality determine
protective efficacy against reinfection. Heterologous
prime boost vaccination minimizes contraction of
anamnestic effectors and maximizes memory CD8+
T cell quantity but reportedly erodes proliferative po-
tential and protective efficacy. This study exploited
heterologous prime boost vaccination to discover
parameters regulating effector CD8+ T cell contrac-
tion and memory differentiation. When abundant
memory T cells were established, boosting induced
only 5–8 cell divisions, unusually rapid memory
T cell differentiation as measured by phenotype
and mitochondrial bioenergetic function, long-lived
survival of 50% of effector T cells, and preservation
of proliferative potential. Conversely, boosting
in situations of low memory CD8+ T cell frequencies
induced many cell divisions, increased contraction
of effector cells, and caused senescence, low mito-
chondrial membrane potential, and poorly protective
memory. Thus, anamnestic memory T cell differen-
tiation is flexible, and abundant quantity can be
achieved while maximizing protective efficacy and
preserving proliferative potential.
INTRODUCTION
Vaccine-elicited memory CD8+ T cells may provide an important
correlate of protection against diseases for which humoral
immunity may not suffice, including AIDS, malaria, and hepatitis
C (Schmidt et al., 2008; Zielinski et al., 2011). In animal models,
memory CD8+ T cell-dependent protective immunity depends
upon both the quantity and quality of pathogen-specific cells
present within the host immediately prior to exposure (Hansen
et al., 2011; Liu et al., 2008), highlighting the need to understand
the cellular events that regulate memory CD8+ T cell differentia-
tion and then to translate these findings into effective vaccine
strategies.
Upon priming, activated CD8+ T cells undergo a rapid burst
of 15–20 cell divisions. Notably, divisions occur as quickly asevery 4–6 hr or 4-fold faster than the cell doubling rate of
immortal HeLa cells (Murali-Krishna et al., 1998). Proliferation
is coupled with differentiation that typically leads to a dramat-
ically expanded population of effectors that helps eliminate
intracellular sources of foreign antigen. Shortly thereafter,
most effector cells die en masse, and only 5%–10% differen-
tiate into long-lived memory CD8+ T cells (Masopust et al.,
2004). Interestingly, antigen encounter induces several rounds
of division, even if antigen is withdrawn before the first cell
division, suggesting that activated T cell proliferation proceeds
autonomously (Kaech and Ahmed, 2001; van Stipdonk et al.,
2001; Wong and Pamer, 2001). It has been proposed that
the onset of contraction (typically occurring 1 week after
infection in mice) occurs independently of the magnitude of
expansion or the dose and duration of antigen, indicating
that contraction may also be a ‘‘programmed’’ homeostatic
feature of the CD8+ T cell response (Badovinac et al., 2002).
Considerable work has been performed to identify those pre-
cursors during the effector phase of the response that survive
and become memory CD8+ T cells and the parameters that
regulate this fate decision (Jameson and Masopust, 2009). Of
note, CD127 (interleukin-7 receptor a [IL-7Ra]) expression is
necessary, but not sufficient, for survival, and it marks memory
precursors and memory T cells (Hand et al., 2007; Kaech et al.,
2003). Expression of killer cell lectin-like receptor G1 (KLRG1),
the transcription factors T-bet and eomes, Id2 and Id3, Bcl-2,
Bcl-6, Blimp-1, Bim, Fas, and metabolism genes are also
correlated with effector CD8+ T cell contraction versus survival
(Cui and Kaech, 2010; D’Cruz et al., 2009; Intlekofer et al.,
2005; Pearce, 2010; van der Windt et al., 2012). Extrinsically,
many parameters, including the cytokine milieu, as well as
the density and duration of antigen, inflammation, and costi-
mulation, regulate CD8+ T cell contraction (Harty and Badovi-
nac, 2008; Joshi and Kaech, 2008; Zehn et al., 2012). Recent
studies focusing on mTOR, autophagy, and the switch
between an anabolic to a catabolic metabolic state indicate
that loss of antigen-specific effector T cells may be fundamen-
tally related to the preservation of metabolic fitness through the
effector period of very rapid division (Araki et al., 2009; Pearce
et al., 2009; van der Windt et al., 2012). Translating these
myriad findings into effective vaccine strategies remains the
ultimate goal.
Heterologous prime-boost (HPB) vaccination involves
repeated immunizations with serologically non-cross-reactiveImmunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc. 171
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Figure 1. Effector CD8+ T Cell Survival
Increases with Each Boost
(A) Seven and 40 days after 1, 2, or 3 immuni-
zation, splenocytes were stained with aCD8 and
aCD44 Abs and H-2Kb-N tetramers (plots gated
on CD8+ lymphocytes).
(B) Dynamics of the 1 and 3 H-2Kb-N-specific
CD8+ T cell response in blood.
(C) Number of H-2Kb-N-specific CD8+ T cells per
mL of blood 7 and 60 days after 1 or 3 immuni-
zation, with the fold difference indicated.
(D) The number of H-2Kb-N-specific CD8+ T cells
isolated from spleen on days 4, 6, and 7 and (E) on
days 6 and 40 with fold difference indicated. **p <
0.01, ***p < 0.001, unpaired Student’s t test.
Graphs show mean ± SEM (n = 5 per experiment)
and are representative of three independent
experiments.
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Regulating Anamnestic Memory Fate and Functionvectors expressing common antigens that induce sequential
reactivation of established memory CD8+ T cells (Woodland,
2004). This strategy results in the establishment of greater
numbers of antigen (Ag)-specific memory CD8+ T cells than
achieved by a single immunization due to the elevated number
of antigen-specific precursors in immune hosts compared
to naive hosts and also because anamnestic CD8+ T cell
responses may undergo less contraction than primary re-
sponses (Grayson et al., 2002; Masopust et al., 2001a). The
potential of HPB vaccination to induce abundant memory
CD8+ T cells is highlighted by reports indicating that three
immunizations in mice with live replicating vesicular stomatitis
virus (VSV) and vaccinia virus (VV) vectors results in an increase
in the total size of the memory CD8+ T cell compartment, and
frequencies of memory CD8+ T cells specific for a single
epitope exceed 50% of all CD8+ T cells in blood (Masopust
et al., 2006; Vezys et al., 2009).
HPB vaccines are in development against AIDS, malaria, and
cancer because they establish a high quantity of memory CD8+
T cells. However, studies suggest that HPB vaccination can
result in proliferatively senescent memory CD8+ T cells, which
may limit their contribution to protection (Joshi and Kaech,
2008; Masopust et al., 2006). For instance, boosted CD8+
T cells exhibit a gene expression profile similar to exhausted
CD8+ T cells observed during chronic infections and have
reduced proliferative and protective capacity against lympho-
cytic choriomeningitis virus clone 13 (LCMV Cl13) infection
upon transfer to naive hosts (Nolz and Harty, 2011; Wirth
et al., 2010). These studies raise questions of whether memory172 Immunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc.CD8+ T cell quantity can be achieved
without eroding quality and functional
potential (Ji et al., 2011). This study
leveraged the unique situation of mini-
mized contraction generated by HPB
vaccination to interrogate the parame-
ters that regulate survival and memory
commitment. Moreover, we explored
conditions under which the function
and proliferative potential of anamnestic
memory CD8+ T cells might be pre-served to achieve cytotoxic T lymphocyte (CTL) memory that
is abundant, functional, and protective.
RESULTS
Effector CD8+ T Cell Survival Increases with Each Boost
In order to test the effect of boosting on survival of effector CD8+
T cells into the memory pool, we utilized a HPB vaccination
strategy. Mice were immunized once, twice, or thrice with sero-
logically distinct viruses that each stimulate an H-2Kb-N52–59
specific CD8+ T cell response (Figure 1A). Mice were rested
60–90 days between immunizations. As shown in Figure 1B,
primary (1) responses peaked 7 days after infection in blood.
Tertiary (3) responses peaked earlier, and the number of
H-2Kb-N-specific CD8+ T cells in blood remained stable on
days 4–7 after immunization. Fold contraction was quantified
by dividing the number of blood-borne H-2Kb-N tetramer+
CD8+ T cells present 7 days after the final immunization by the
number present at day 90 and revealed that boosting resulted
in decreased contraction in blood (Figure 1C). Similar observa-
tions were made in spleen (Figures 1D and 1E) and mucosal
nonlymphoid tissues (data not shown).
Acquisition of Memory Phenotype Is Accelerated after
3 Immunization
To investigate why each recall CD8+ T cell response underwent
less contraction, we analyzed the phenotype of Ag-specific
CD8 T splenocytes six days after 1, 2, and 3 infections (Fig-
ure 2A). Paradoxically, KLRG1 and T-bet expression, which
Immunity
Regulating Anamnestic Memory Fate and Functioninversely correlates with survival inmany reports (Cui and Kaech,
2010), was actually equivalent or even increased with each
boost. However, other markers predictive of commitment to
the memory lineage, CD127, and the prosurvival factor Bcl-2,
increased expression. Meanwhile, two markers associated
with recently primed effectors, granyzme B and programmed
death-1 (PD-1), exhibited decreased expression with each
boost. In other words, 3 responders shared many similarities
with memory CD8+ T cells within only 6 days of stimulation.
One explanation is that 3 responses contained a large fraction
of 2 memory CD8+ T cells that failed to be stimulated.
To investigate this possibility, we labeled CD45.1+ 2 memory
CD8+ T cells with CellTrace Violet (CTV) and then transferred
into infection-matched CD45.2+ 2 immune recipients. The
following day, recipients were immunized with VSV-Ind, and
the 3 response was monitored in peripheral blood mononuclear
cells (PBMC). As shown in Figure 2B, almost all donor H-2Kb-N
tetramer+ CD8+ T cells underwent division in response to 3 stim-
ulation, suggesting that the memory-like phenotype observed in
Figure 2A was not due to a failure in activation. However, we
noted that donor cells did not completely dilute CTV and stopped
dividing within only 4–5 days of immunization.
To interrogate whether 3 responders underwent a canonical
effector phase before day 6 after immunization, we investigated
CD127 and granzyme B expression at earlier time points in
PBMC. As shown in Figure 2C, granyzme B expression was uni-
formly expressed by 3 responders within 24 hr of immunization
but was largely downregulated within 4 days. Likewise, CD127
was downregulated early in the response, but rapidly upregu-
lated 3–6 days after immunization (Figures 2D and 2E). Thus,
3 responders went through a brief period of effector differentia-
tion and almost immediate upregulation of granzyme B and then
rapidly acquired memory characteristics prior to the contraction
phase of the response. It should be noted that granzyme
B expression among 3 splenocytes remained slightly elevated
compared to naive and 1 memory splenocytes for at least
3 months after immunization (data not shown).
Increased Mitochondrial Function and Proliferation
Potential 7 Days after 3 Immunization
Memory CD8+ T cells exhibit an increased basal O2 consumption
rate (OCR) and spare respiratory capacity (SRC) in comparison
to effector and naive CD8+ T cells (van der Windt et al., 2012).
SRC defines the reserve ATP generation capacity of total cellular
mitochondria and has been linked to cell-stress resistance
and survival (Nicholls, 2009; Yadava and Nicholls, 2007). As 3
responding T cells bore phenotypic markers of memory differen-
tiation within 7 days of stimulation, we addressed whether they
exhibited metabolic signatures of memory T cells as well. By
using various inhibitors of the mitochondrial electron transport
chain and the Seahorse instrumentation platform for measuring
O2 consumption in live cells (as described, Wu et al., 2007), we
compared OCR and SRC among purified H-2Kb-N tetramer+
CD8+ T cells isolated from spleen 7 days after 1 or 3 immuniza-
tion. As shown in Figure 3A, compared to 1 effectors, 3
responders exhibited greater basal OCR and SRC (SRC is calcu-
lated as the difference between maximum OCR after FCCP
injection and basal OCR). Consistent with this functional
readout, 3 responders also exhibited increased mitochondrialmass when compared to 1 effectors on a per cell basis
(as measured by staining with the mitochondria-selective fluo-
rescent label Mitotracker Green, Figures 3B and 3C).
To compare the per cell in vivo proliferative potential of 1 and
3CD8+ T cells isolated 7 days after immunization, 5 3 104
H-2Kb-N tetramer+ CD8 T splenocytes were transferred into
naive recipients. The following day, recipient mice were immu-
nized with VSV-Ind, and the recall response in blood was
compared 7 days later (the peak for both populations). As shown
in Figure 3D, day 7 3CD8+ T cells exhibited greater reserve
proliferative capacity than 1 effectors.
Increasing Ag-Specific Memory CD8+ T Cell Abundance
Favors Their Memory Commitment after Restimulation
The phenotype and division potential of 1 and 3 responsesmay
vary solely due to T cell intrinsic differences between naive and
2 memory T cells prior to immunization. Alternatively, host envi-
ronmental differences stemming from the increase in Ag-specific
T cell frequency that accompanies immunization may have influ-
enced T cell differentiation. Indeed, Ag-persistence, inflamma-
tion, T cell competition for cytokines and antigen presenting
cell (APC) interaction, and innumerable other variables are
inalienably coupled with T cell frequency. Therefore, we altered
the precursor frequency of antigen-specific CD8+ T cells
and compared cell divisions, phenotype, and contraction. We
isolated 83 105 H-2Kb-N tetramer+ CD8+ T cells from 2 immune
(VSVnj-VVn) CD45.1+ mice, labeled with CTV, and transferred
either to 2 immune or to naive CD45.2+ recipients. The next
day, recipients were infected with VSV-Ind. CTV dilution was
assessed on donor tetramer+ CD8 T lymphocytes in blood
7 days later. As shown in Figures 4A and 4B, dilution of 2 mem-
ory CD8+ T cells via transfer to naive mice resulted in complete
dilution of CTV upon 3 immunization. These results suggest
that 2 memory CD8+ T cells are capable of undergoing R10
cell divisions upon 3 stimulation but, remarkably, that they
prematurely arrest division only when they are very abundant.
We then investigated the relationship between 2 memory
CD8+ T cell precursor frequency and the corresponding pheno-
type and contraction phase of a 3 response. To this end,
H-2Kb-N tetramer+ CD8+ T cells were isolated from 2 immune
(VSVnj-VVn) CD45.1+ mice and transferred to 2 immune
CD45.2+ recipients (resulting in an undiluted precursor popula-
tion). For comparison, we transferred 2 3 105 (resulting in a
40-fold dilution relative to ‘‘intact’’ 2 immune mice) or 2 3 103
(resulting in a 4,000-fold dilution relative to ‘‘intact’’ 2 immune
mice, which approximates the precursor frequency estimated
in naive mice, Obar et al., 2008) CD45.1+ H-2Kb-N tetramer+
CD8+ T cells into naive CD45.2+ mice. The following day, recip-
ients were boosted. Figure 4C demonstrates that 3 H-2Kb-N
tetramer+ CD8+ T cell phenotype corresponded to precursor
frequency prior to immunization. As 2 memory CD8+ T cells
were diluted to naive precursor frequencies, we observed
much more pronounced downregulation of CD127 and Bcl-2
6 days after immunization. To examine the dynamics of CD127
downregulation more closely, we compared expression among
undiluted and 403 diluted populations 3 days after 3 stimula-
tion. Interestingly, CD127 expression was similar between the
two populations when cells that underwent equivalent numbers
of cell divisions were compared. Moreover, CD127 expressionImmunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc. 173
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Figure 3. Increased Mitochondrial Function and Proliferation Potential 7 Days after 3 Immunization
(A) H-2Kb-N-specific CD8+ T cells were purified from spleen 7 days after 1 or 3 immunization. Oxygen-consumption rates (OCR) were measured under basal
conditions and after injection of the indicated mitochondrial inhibitors. SRC can be determined by measuring the difference between the maximumOCR induced
by uncoupling the electron transport chain by FCCP injection and the basal OCR.
(B) H-2Kb-N-specific CD8+ T cells were purified from spleen 4.5 or 7 days after 1 or 3 immunization, stained with Mitotracker Green, CD8a, and DAPI, and
visualized by confocal microscopy.
(C) The ratio of themean fluorescence intensity ofMitotracker Green staining (mitochondrial DNA) to DAPI staining (nuclear DNA). Graph showsmean ± SEM from
one of two experiments with similar results, andR100 cells from each of five mice were analyzed per experiment.
(D) We isolated 53 105 purified H-2Kb-N-specific CD8+ T cells from spleen 7 days after 1 or 3 immunization and then transferred them into naive recipients. The
following day, recipients were challenged with VSV-Ind, and the number of antigen-specific donor cells was determined after 1 week. Graph shows mean ± SEM
from one of two experiments with similar results. For statistics, *p < 0.05 and ***p < 0.001, unpaired Student’s t test.
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Regulating Anamnestic Memory Fate and Functionprogressively decreased with each cell division among both
populations (Figures 4D and 4E). In addition, as 2 memory pre-
cursor frequencies were diluted, we observed much greater
contraction between the numeric peak of the response and the
number of donor CD45.1+ H-2Kb-N tetramer+ CD8+ T cells
present 60 days later (Figure 4F). These results indicate that
increased 2memoryCD8+ T cell precursor frequency correlated
strongly with reduced cell divisions, faster conversion to a
memory phenotype, and enhanced longevity of the responding
population.Figure 2. Acquisition of Memory Phenotype Is Accelerated after 3 Imm
(A) Phenotype in spleen 6 days after 1, 2, or 3 immunization (plots gated on H
(B) Splenocytes isolated from 2 immune CD45.1+ mice were labeled with CTV
donor CD45.1+ H-2Kb-N tetramer+ CD8 T lymphocytes in blood 3–6 days after 3
(C) Granzyme B expression was measured on H-2Kb-N-specific CD8+ T cells in
(D) Percent CD127+ among H-2Kb-N-specific CD8+ T cells after 1 versus 3 imm
(E) As in (B), CTV labeled splenocytes from 2 immune CD45.1+ mice were tran
expression among donor CD45.1+ H-2Kb-N-specific CD8+ T cells after 3 immunProliferative Potential of Boosted Memory T Cells Can
Be Preserved or Eroded
As endogenous memory precursor frequency impacted effector
cell survival, we wished to test whether it also regulated the qual-
ity of resulting memory CD8+ T cells. To this end, we compared
the differentiation and proliferative potential of 3 memory CD8+
T cells raised in a single ‘‘intact’’ host, or in a serial adoptive
transfer model of prime boost vaccination, where the precursor
frequency of memory CD8+ T cells is artificially maintained at
low levels prior to each boost (see Figure 5A for experimentalunization
-2Kb-N tetramer+ CD8 T lymphocytes).
and transferred into 2 immune CD45.2+ mice. CTV dilution was assessed on
 immunization. Donor and recipient tetramer cells are shown as controls.
blood on the days indicated after 3 immunization.
unization (mean ± SEM).
sferred into 2 immune CD45.2+ mice. Kinetics of CTV dilution versus CD127
ization.
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Figure 4. Increasing Ag-Specific Memory CD8+ T Cell Abundance Favors Their Memory Commitment after Restimulation
(A) Splenocytes isolated from 2 immune CD45.1+ mice were labeled with CTV and transferred to 2 memory (undiluted) or naive (diluted) CD45.2+ mice. The next
day, recipients were immunized with VSV-Ind. CTV dilution was assessed on donor tetramer+ CD8 T lymphocytes in blood 7 days later. Donor and recipient
tetramer cells are shown as controls.
(B) Frequency of tetramer+ donor cells present in each CTV division peak.
(C) Precursor frequencywasmodified by transferring various numbers of 2 memoryCD8+ T cells to immune or naive recipients. CD127 and Bcl-2 expressionwas
assessed on donor H-2Kb-N-specific CD8+ T cells 7 days after 3 immunization. The 1 response in mice that received no cell transfer is shown as a control.
(D) CTV versus CD127 expression and (E) the geometric mean fluorescence intensity (GMFI) of CD127 in each CTV division peak among undiluted and 403
diluted donor cells 3 days after 3 infection.
(F) Number of donor H-2Kb-N-specific CD8+ T cells isolated from spleen 60 days after 3 immunization was divided by the number isolated 7 days after
immunization. *p < 0.05, **p < 0.01, unpaired Student’s t test. Graphs show mean ± SEM and are representative of three independent experiments totalingR12
mice per group.
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Regulating Anamnestic Memory Fate and Functiondesign). As shown in Figure 5B, artificially reducing the precursor
frequency prior to each boost had profound consequences on
resulting memory, resulting in 3 memory CD8+ T cells with
eroded mitochondrial membrane potential. These data demon-
strate that high precursor frequencies prior to each boost (which
are associated with briefer bursts of subsequent cell division)
correlated with preservation of mitochondrial integrity on result-
ing memory cells. Serial adoptive transfer was also associated
with protracted and impaired CD127 upregulation (Figures 5C
and 5D). To compare proliferative potential on a per cell basis,
we transferred purified CD8+ T cells containing 2.5 3 104
H-2Kb-N tetramer+ CD8+ T cells generated by either method
into naive recipients, then challenged recipients with VSV-Ind
to elicit a 4 response. As shown in Figure 5E, the ‘‘intact’’ pop-
ulation exhibited much greater proliferative potential, resulting in176 Immunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc.25-fold more daughter cells recovered from spleen, small
intestinal epithelium (SI IEL), or lamina propria (SI LP). Indeed,
4 effector cells generated by serial transfer underwent fewer
divisions (Figure 5F), indicative of proliferative senescence. In
summary, boosting can erode the proliferation capacity and
mitochondrial membrane potential of resulting memory T cells.
However, this is not an axiomatic outcome of multiple stimula-
tions but will vary depending on the vaccine strategy.
Functions of Memory CD8+ T Cells Can Be Preserved
Despite Boosting
Boostedmemory T cell quality varied considerably depending on
the context of prior antigen stimulation. We then wished to
compare the quality of boosted memory CD8+ T cells that were
raised in ‘‘intact’’ hosts with 1 memory CD8+ T cells. We
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Figure 5. Proliferative Potential of Boosted Memory T Cells Can Be Preserved or Eroded
(A) We generated 3 memory CD8+ T cells via two different methods. Method 1 (Intact): naive CD45.1+ C57BL/6J mice were immunized three times at 30 day
intervals. Method 2 (Serial Transfer, ST): 1 and 2 memory T cells were diluted before each boost by transferring 2.5 3 104 purified CD45.1+ H-2Kb-N CD8+
memory T cells to naive CD45.2+ mice. Thirty days after 3 immunization, 2.53 104 tetramer+ CD8+ T cells generated by eachmethod were transferred into naive
mice and then exposed to a 4 immunization.
(B) Ninety days later, mitochondrial membrane potential was determined on H-2Kb-N tetramer+ CD45.1+ donor cells by incubating with DiOC2(3), a cyanine dye
that accumulates in mitochondria with active membrane potentials. Negative control samples were treated with CCCP (carbonyl cyanide 3-chlorophenylhy-
drazone), which disrupts mitochondrial membrane potential.
(C) Comparison of CD127 expression dynamics after 2 and 3 immunization (method 1 versus 2) and (D) KLRG1 and CD127 expression in the spleen 30 days
after 3 immunization.
(E) Proliferative capacity was assessed by determining the number of CD45.1+ tetramer+ cells in various tissues 6 days after transfer and 4 immunization.
(F) As in (E), but donor cells were CTV-labeled prior to transfer, and CTV dilution was examined. Graphs show mean ± SEM from one of three experiments with
similar results totaling 15 mice. For statistics, **p < 0.01 and ***p < 0.001, unpaired Student’s t test.
Immunity
Regulating Anamnestic Memory Fate and Functiongenerated 1 and 3 memory CD8+ T cells in intact hosts, as
described in Figure 1A. Forty days after final immunization, sple-
nocyteswere evaluated for interferon-g (IFN-g) or tumor necrosis
factor-a (TNF-a) production after 5 hr in vitro stimulation by intra-
cellular staining. Asshown inFigure 6A, theproportionof cytokine
producing cells relative to the proportion of H-2Kb-N tetramer+cells was similar with each boost.We also failed to detect any dif-
ference in antigen sensitivity, as determined by titrating cognate
peptide and assessing loss of IFN-g production (Figure 6B).
To compare 1 and intact 3 memory CD8+ T cell function on a
per cell basis upon further in vivo stimulation, we transferred
2.53 104 purified, CTV-labeled, antigen-specific CD45.1+ CD8+Immunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc. 177
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Figure 6. Functions of Memory CD8+ T Cells Can Be Preserved Despite Boosting
(A) Forty days after immunization, 1 or 3CD8 T splenocytes were evaluated for IFN-g or TNF-a production after 5 hr in vitro stimulation by intracellular staining
and compared with the percentage of H-2Kb-N tetramer+ cells within the sample (3 cells were diluted with splenocytes from naive mice in order to match the
H-2Kb-N tetramer+ cell frequency of 1 mice before stimulation).
(B) Percent maximum number of IFN-g+ cells in response to varying concentrations of cognate peptide.
(C–F) We isolated 2.53 104 H-2Kb-N tetramer+ CD8 T splenocytes from 1 and 3 immune CD45.1+ mice, labeled themwith CTV, and transferred them into naive
CD45.2+ mice. Recipients were then immunized with VSV-Ind (resulting in either a 2 or 4 stimulation), and donor CD45.1+ H-2Kb-N tetramer+ CD8+ T cells were
analyzed 6 days later. (C) Number of expanded donor cells recovered from the indicated tissues. (D) CTV dilution on donor CD45.1+ H-2Kb-N tetramer+ CD8+
T cells. Donor and recipient tetramer cells shown as controls. (E) Production of IFN-g or TNF-a after 5 hr stimulation. (F) GranzymeB expression in various tissues
(gated on CD44lo or H-2Kb-N tetramer+ CD8+ T cells, as indicated). Experiments were performed two (A) or three (B–F) times (totaling 10–15 mice) with similar
results. Graphs show mean ± SEM, ns = not significant, ***p < 0.001, unpaired Student’s t test. See also Figure S1.
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Regulating Anamnestic Memory Fate and FunctionT cells to CD45.2+ naive recipients. The next day we challenged
recipient mice with VSV-Ind. We found that donor H-2Kb-N
tetramer+ cells isolated from both 1 and 3 immunized mice
completely diluted CTV and both populations underwent equiv-
alent expansion (Figures 6C and 6D) six days after stimulation.
Further comparison revealed that 4 effectors showed a
decrease in the ability to express TNF-a upon ex vivo stimulation
(Figure 6E), although granzyme B expression was equivalent
immediately ex vivo (Figure 6F). Interestingly, CD4+ T cell help
was not required during 3 responses for optimal CD8+ T cell
expansion or preservation of proliferative potential among result-
ing memory cells (see Figure S1 available online).
Protective Capacity of Boosted Memory CD8+ T Cells
Reflects Stimulation History
Recent reports demonstrate that 2 memory cells, generated by
serial transfer of transgenic P14 CD8+ T cells specific for the im-178 Immunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc.munodominant gp33 epitope of lymphocytic choriomeningitis vi-
rus (LCMV), exhibit signs of functional exhaustion (Wirth et al.,
2010) and fail to protect against the chronic infection inducing
Clone 13 (Cl-13) strain of LCMV (Nolz and Harty, 2011). In com-
parison, 1 memory CD8+ T cells, which have much greater pro-
liferative potential, were protective. Because Figures 5 and 6
showed that proliferative senescence results from serial transfer
of memory cells, we reexamined this issue.
We generated 2 memory Thy1.1+ P14 cells by transferring
5 3 103 naive P14 cells into C57BL/6J recipients, infecting
with LM-gp33, resting mice for R60 days, and then boosting
with VV-gp33. We also generated 1 and 2 memory P14
cells with serial transfers and LCMV Armstrong infections, as
described (Nolz and Harty, 2011). To compare the protective
capacity of each population on a per cell basis against LCMV
Cl-13 challenge, we transferred 2.5 3 105 of each memory P14
population into naive mice. Recipients were infected with
Figure 7. Protective Capacity of Boosted Memory CD8+ T Cells Reflects Stimulation History
(A) Naive C57BL/6J mice receiving no cells (naive), 2.53 105 serially diluted 2 memory P14 CD8+ T cells (2.53 105 ST 2), 2.53 105 intact 2 memory P14 CD8+
T cells (2.53 105 2), 2.53 105 1 memory P14 CD8+ T cells (2.53 105 1), or intact 2 immunized (2 immune) mice were challenged with LCMV clone 13. Viral
titers were analyzed in the spleen 3 and 10 days after infection.
(B–F) Naive C57BL/6J mice receiving no cells (naive), 5 3 105 or 2 3 104 intact 3CD45.1+ H-2Kb-N tetramer+ CD8+ T cells, 2 3 104 serially diluted 3CD45.1+
H-2Kb-N tetramer+ CD8+ T cells, or 2 3 104 intact 1CD45.1+ H-2Kb/N tetramer+ CD8+ T cells were challenged i.v. with VV-N. H-2Kb-N tetramer+ CD8+ T cells
were sorted by flow cytometry (>98% purity) prior to transfer. (B) Viral load 7 days after infection. (C) CD45.1+ H-2Kb-N tetramer+ CD8+ T cells recovered from
spleen. (D–F) CD45.1+ cells present in ovaries 7 days after VV-N challenge. Scale bars represent 500mm (white) and 20mm (yellow). Dashed line indicates limit of
detection (LOD). ns = not significant, *p < 0.05, **p < 0.01,***p < 0.001, unpaired Student’s t test. Error bars indicate SEM. Symbols represent individual mice. See
also Figure S2.
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comparison, intact heterologous prime-boosted mice were
also infected. Serially diluted 2 memory CD8+ T cells failed to
clear infection from spleen (Figure 7A) and kidney (Figure S2).
In contrast, detectable virus was largely eliminated in mice that
received either 1 memory CD8+ T cells or ‘‘intact’’ 2 memory
CD8+ T cells. These results demonstrate that protective capacity
on a per cell basis against LCMV Cl-13 infection can be pre-
served or eroded by boosting. Strikingly, when intact boosted
micewere directly challenged, viral loadwas undetectable within
3 days of challenge (Figure 7A; Figure S2), demonstrating that
preservation of both quantity and quality may afford the most
protection.
We next tested these principles in the endogenous infectious
system described in Figures 1–6. We generated intact 1, 3,
or serial transferred 3 memory CD8+ T cells in CD45.1+ mice.We transferred 2 3 104 of each population to naive recipients,
which were then challenged with VV-N. Seven days later, viral
load was determined by plaque assay in the ovaries (Figure 7B).
Intact 1 and 3 memory CD8+ T cells contributed equivalently to
viral control, whereas serially transferred 3memory CD8+ T cells
did not affect viral titers. Because low numbers of memory CD8+
T cells were transferred, protection was likely dependent on the
degree of clonal expansion following viral challenge. Consistent
with this interpretation, only intact 1 and 3 memory CD8+
T cells underwent substantial expansion in response to viral
challenge, which resulted in larger effector populations present
within both lymphoid organs and peripheral sites of infection
(Figures 7C–7F). Moreover, when 25-fold more intact 3 memory
CD8+ T cells were transferred (5 3 105 purified tetramer+ cells),
the resulting effector population was larger and viral control
was more effective (Figures 7B, 7C, and 7F). Together, theseImmunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc. 179
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entiation is flexible, and abundant quantity can be achievedwhile
maximizing protective efficacy and preserving proliferative
potential.
DISCUSSION
Many studies on CD8+ T cell vaccination and memory function
disengage the enhancement in quantity provided by priming or
boosting from the qualitative effects of repeated stimulation.
This reductionist approach, often involving a dilution in memory
T cell frequencies via adoptive transfer, provides technical and
conceptual advantages and provides ‘‘per cell basis’’ compari-
sons with naive T cells (Jabbari and Harty, 2006; Martin et al.,
2012; Masopust et al., 2006; Nolz and Harty, 2011; West et al.,
2011;Wirth et al., 2010). Amajor conclusion that has been gener-
alized from these studies is that amplifying memory CD8+ T cell
quantity, a desired outcome for vaccines that target clinically
relevant pathogens and cancer, comes at the expense of pro-
moting senescence and dysfunction. These studies are consis-
tent with the observation that extended T cell expansion, in vivo,
or in vitro in the context of adoptive cancer immunotherapy, out-
paces the function of telomerase induced upon antigen stimula-
tion and is associated with telomere shortening and replicative
senescence (Hathcock et al., 2003; Weng et al., 1996; Zhou
et al., 2005). Our current study shows that both quantity and
quality may be achieved. Upon revaccination, in a setting where
abundant endogenous CD8+ T cell memory has been estab-
lished, anamenstic responses were remarkably robust (Figure 1),
and correlated with few effector cell divisions, very rapid and effi-
cient memory differentiation (Figures 2 and 3), and preservation
of memory T cell function and proliferative potential (Figures 5
and 6). Conversely, revaccination of mice containing few mem-
ory cells correlated with many effector cell divisions, profound
contraction, slow acquisition of a memory phenotype, and the
induction of replicative senescence among resulting memory
CD8+ T cells (Figure 5). These results provide insight into the
parameters that regulate memory differentiation.
Modifying naive precursor frequencies via transfer of trans-
genic T cells, a common artifact of experimental design in mice
that is unlikely to be translated to the vaccine setting, effects
1 effector T cell expansion and contraction, as well as resulting
memory T cell phenotype and function (Badovinac et al., 2007;
Marzo et al., 2005; Sarkar et al., 2007; van Faassen et al.,
2005). Our results suggest that manipulating the quantity of
memory T cells established via vaccination also impacts effector
T cell expansion and differentiation. Indeed, the amount and
duration of inflammation and Ag stimulation regulate primary
T cell expansion and contraction, and these variables are interre-
lated with the quantity of preexisting T cell memory upon boost-
ing (Blair et al., 2011; Catron et al., 2006; D’Souza and Hedrick,
2006; Joshi et al., 2007; Obar et al., 2011; Sarkar et al., 2007). A
major conclusion of this study is that experiments that artificially
dilute memory T cells are unlikely to accurately predict T cell dif-
ferentiation following physiological HPB vaccination in humans.
Nevertheless, boosting has been shown to induce T cell intrinsic
changes that bias the response toward a T cell effector-memory
(TEM) phenotype, as well as increased IL-12 responsiveness and
expression of KLRG1 and T-bet (Tbx21) transcription factor;180 Immunity 39, 171–183, July 25, 2013 ª2013 Elsevier Inc.phenotypes that correlate with increased contraction of effectors
and terminal differentiation and replicative senescence among
resulting memory cells (Jabbari and Harty, 2006; Joshi et al.,
2007; Masopust et al., 2006; Voehringer et al., 2001). It has
been proposed that this cell fate is not caused by an accumula-
tion of cell divisions or the number of Ag encounters but rather by
T-bet expression (Joshi et al., 2007; Joshi and Kaech, 2008).
In this case, naturally increasing preexisting memory T cell
numbers through vaccinationmay restrict terminal differentiation
by limiting T-bet. Indeed, we found no increase in T-bet expres-
sion on effectors with each boost (Figure 2A), and no increase
among 2 or 3 memory cells (data not shown), in contrast to
serial transfer prime-boost models that artificially dilute cells
(Joshi et al., 2011).
CD8+ T cells control intracellular infections in a cell contact-
dependent manner and therefore must survey large numbers
of host cells. This is an extraordinary challenge given the
collective diversity of specificities that must be exhibited by the
naive lymphocyte repertoire and, consequently, the extremely
low frequency of naive CD8+ T cells specific for any single path-
ogen. Accordingly, rare pathogen-specific CD8+ T cells must
expand profoundly and quickly, undergoing cell division every
4–6 hr and accumulating 20 cell divisions within only a few
days. To our knowledge, no mammalian cell type, including
immortalized cell lines grown in vitro under optimum conditions,
is able to indefinitely sustain this rate of cell division. Energeti-
cally, the rate of CD8+ T cell proliferation is all the more impres-
sive given that they must contemporaneously produce antimi-
crobial products and cytotoxic granules. We propose a model
whereby effector CD8+ T cells are essentially allowed to break
ametabolic speed limit in which cell division outpacesmitochon-
drial biogenesis and may also be associated with a failure to
keep pace with DNA repair and the elimination of cellular waste
products and reactive oxygen species. The price for this division
rate, coupled with sustained effector gene expression, may
contribute to apoptosis of the majority of the responding
population. It should be noted that those cells that survive the
contraction phase of a primary response require weeks of rest
before acquiring the cardinal signatures of a fit memory CD8+
T cell capable of optimal contributions to a secondary challenge
(Kaech et al., 2002).
We found that 3 immunization induced an unusually small
number of cell divisions that correlated with a rapid effector
phase, preservation of mitochondrial mass, and expression of
memory phenotypic and bioenergetic signatures within only
4–7 days (Figures 1, 2, and 3), a time point that precedes the
contraction phase of the 1 response. It is unclear whether divi-
sions were limited as a result of competition for an essential
resource or quorum sensing, but they likely protect the host
from unnecessarily excessive CD8+ T cell expansion. Fifteen
cell divisions among 2 memory CD8+ T cells would result
in 1010 3 effectors, which approximates the total number of
somatic cells in the mouse and is obviously not bioenergetically
possible. More importantly, this limited number of cell divisions
also may protect the T cell. First of all, it results in minimal
contraction (Figures 1 and 2). Moreover, it preserves mitochon-
drial function and the potential to robustly undergo future rounds
of cell division (Figures 3, 4, 5, and 6). In contrast, when T cells
are forced to iteratively undergo 20 cell divisions as an artifact
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impaired mitochondrial function and were senescent (Figures 5,
6, and 7).
In conclusion, preternaturally abundant anamnestic memory
CD8+ T cells could be established that maintained proliferative
potential and expansion-dependent protection against viral
challenge. These data have implications for adoptive immuno-
therapy and indicate that vaccinemodality, including the number
of memory cells established upon each immunization, is critical
for maintaining (or eroding) memory T cell function.EXPERIMENTAL PROCEDURES
Mice and Infections
C57BL/6J mice were purchased from The Jackson Laboratory. All mice were
used in accordance with National Institutes of Health and the University of Min-
nesota Institutional Animal Care and Use Committee guidelines. For the anal-
ysis of intact 1CD8+ T cell responses to vesicular stomatitis virus (VSV), mice
were infected by intravenous (i.v.) injection of 1 3 107 PFU VSV of the Indiana
(Ind) serotype. For the analysis of intact 2CD8+ T cell responses, mice were
primed by i.v. injection of 1 3 106 PFU VSV of the New Jersey serotype (NJ),
rested for 60–90 days unless otherwise indicated and then rechallenged with
VSV-Ind. For analysis of intact 3CD8+ T cell responses, mice were primed
with VSV-NJ, rested for 60–90 days, infected by i.v. injection of 2 3 106 PFU
recombinant vaccinia-N (Yewdell et al., 1986), rested for an additional
60–90 days, then challenged with VSV-Ind. For proliferation experiments,
CD45.1+ congenically marked, splenic cells from 1, 2, or 3 immune mice
(generated as described above) were purified by CD45.2+ CD8+ negative
selection columns (Miltenyi) and transferred into 2 or naive recipients. The
following day, recipients were infected with the indicated virus. To measure
proliferation, we labeled donor cells with CellTrace Violet according to
manufacturer’s protocol (Invitrogen).Isolation of Lymphocytes and Flow Cytometry
Lymphocytes were isolated from spleen and small intestine (SI) as previously
described (Masopust et al., 2001b). The female reproductive tract (FRT),
including uterine horns, cervix, and vaginal tissue, was resected, cut into
5 mm pieces, and treated with 100 U/ml Type IV collagenase (Sigma) in 5%
RPMI 1640/2 mM MgCl2/2 mM CaCl2 for 45 min at 37
C, stirring at 200 rpm.
Lymphocytes from SI and FRT were purified on a 44/67% Percoll gradient
(800xg at 23C for 20min). Single-cell suspensions underwent surface or intra-
cellular staining as described previously (Masopust et al., 2006). Endogenous
VSV-specific CD8+ T cells were identified by staining with H-2Kb tetramers
containing the VSV nucleoprotein-derived peptide RGYVYQGL. Samples
were acquired on an LSRII flow cytometer (BD Biosciences).Metabolic Analyses
Seven days after 1 or 3 immunization, H-2Kb-N-specific splenocytes were
purified by magnetic bead enrichment (Moon et al., 2009, >97%) and OCR
was measured on live cells (plated at a concentration of 5 3 105/well, each
datum represents a mean of three replicates) in nonbuffered, sodium bicar-
bonate-free RPMI 1640 containing 25 mM glucose, 2 mM L-glutamine, and
1 mM sodium pyruvate. Measurements were made under basal conditions
and after treatment with 200 mM etomoxir, 1 mM oligomycin, 1.5 mM fluoro-
carbonyl cyanide phenylhydrazone (FCCP), and 100 nM rotenone (Sigma) with
the XF-24 Extracellular Flux Analyzer according to manufacturer’s protocol
(Seahorse Bioscience). SRC was calculated by subtracting basal OCR from
maximum OCR after FCCP treatment. For analysis of mitochondrial mass,
purified H-2Kb-N-specific splenocytes were stained with Mitotracker Green
(Invitrogen), aCD8, and DAPI, and then imaged by confocal microscopy. For
mitochondrial membrane potential analysis, unsorted lymphocytes were incu-
bated in 40 nM DiOC2(3) (Molecular Probes) diluted in 1% FCS PBS for 30 min
at 37C. The cells were then washed in FACS buffer and stained with anti-CD8,
anti-CD45.1, and H-2Kb-N tetramer prior to preparation for flow cytometric
analysis.Protection Assays
For generation of 1 memory P14 CD8+ T cells, 53 103 naive Thy1.1 P14 CD8+
T cells were isolated from P14 transgenic mice and transferred i.v. into naive
C57BL/6J recipients. Mice were infected the next day with 2 3 105 PFU of
LCMV-Armstrong intraperitoneally (i.p.). For generating 2 serial transferred
memory P14 CD8+ T cells, splenocytes from mice containing 1 memory
P14 CD8+ T cells were stained with PE-anti-Thy1.1 antibody (Clone OX-7,
BD PharMingen), labeled with anti-PE beads, and purified on magnetized col-
umns per manufacturers protocol (Miltenyi). After purification, 53 104 primary
memory Thy1.1 P14 CD8+ T cells were transferred i.v. into naive C57BL/6J
recipients, and recipients were infected 24 hr later with LCMV-Armstrong i.p.
as described (Nolz and Harty, 2011). For generating intact 2 mice, 5 3 103
naive Thy1.1 P14 CD8+ T cells were transferred to naive C57BL/6J recipients.
Mice were infected 24 hr later with 23 103 Listeria monocytogenes expressing
the LCMV epitope gp33 (gift of Hao Shen, University of Pennsylvania). After
60–90 days, these mice were then boosted with 1 3 106 PFU vaccinia virus
expressing gp33.
For LCMV Cl-13 protection assays, we purified and transferred 2.53 105 of
the above memory P14 populations into separate naive mice. Recipients were
infected with LCMV Cl-13 (2 3 106 PFU i.v.). Intact heterologous prime-
boosted P14 chimeric mice were also directly infected. Three and 10 days
after infection, organs were homogenized and viral titers were quantified by
plaque assays on Vero cells as previously described (Welsh and Seedhom,
2008).
For VV-N protection assays, intact or serial transferred CD45.1+ H-2Kb-N-
specific cells were generated as described in Figure 5. H-2Kb-N tetramer+ cells
were then purified (>98% purity) by FACS sorting and transferred into naive
mice. Recipient mice were then challenged with VV-N, and viral load in the
ovary was assessed by plaque assay as previously described (Earl et al.,
2001). For imaging donor cells, frozen blocks were cut into 7 mmsections, fixed
in acetone, and stained with DAPI and aCD45.1. Images were acquired with an
automated Leica DM5500B microscope and analysis of coronal sections was
performed with ImageJ and Adobe Photoshop.
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